News
May 12, 2021

How not to be an enabler: The implications of Amgen v. Sanofi and Regeneron for antibody claims and beyond

Speaker, New Jersey Intellectual Property Law Association (NJIPLA)

People

Subscribe
Subscribe Link

Email Disclaimer